HIGHLIGHTS
- who: Receptor and colleagues from the Tianjin Medical University Nankai Hospital, No, Changjiang Road, Nankai District, Tianjin, China have published the paper: Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor, in the Journal: Evidence-Based Complementary and Alternative Medicine of 30/Nov/2022
- what: Te purpose of this study was to investigate the mechanism and active components of QLTs for treating intrahepatic cholestasis (IHC) in rat models.
- how: Te results showed that this compound can ameliorate the physiological state of model rats and reduce . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.